Are human dental papilla-derived stem cell and human brain-derived neural stem cell transplantations suitable for treatment of Parkinson's disease?

Authors
Yoon, Hyung HoMin, JoongkeeShin, NaniKim, Yong HwanKim, Jin-MoHwang, Yu-ShikSuh, Jun-Kyo FrancisHwang, OnyouJeon, Sang Ryong
Issue Date
2013-05
Publisher
SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES
Citation
NEURAL REGENERATION RESEARCH, v.8, no.13, pp.1190 - 1200
Abstract
Transplantation of neural stem cells has been reported as a possible approach for replacing impaired dopaminergic neurons. In this study, we tested the efficacy of early-stage human dental papilla-derived stem cells and human brain-derived neural stem cells in rat models of 6-hydroxydopamine-induced Parkinson's disease. Rats received a unilateral injection of 6-hydroxydopamine into right medial forebrain bundle, followed 3 weeks later by injections of PBS, early-stage human dental papilla-derived stem cells, or human brain-derived neural stem cells into the ipsilateral striatum. All of the rats in the human dental papilla-derived stem cell group died from tumor formation at around 2 weeks following cell transplantation. Postmortem examinations revealed homogeneous malignant tumors in the striatum of the human dental papilla-derived stem cell group. Stepping tests revealed that human brain-derived neural stem cell transplantation did not improve motor dysfunction. In apomorphine-induced rotation tests, neither the human brain-derived neural stem cell group nor the control groups (PBS injection) demonstrated significant changes. Glucose metabolism in the lesioned side of striatum was reduced by human brain-derived neural stem cell transplantation. [F-18]-FP-CIT PET scans in the striatum did not demonstrate a significant increase in the human brain-derived neural stem cell group. Tyrosine hydroxylase (dopaminergic neuronal marker) staining and G protein-activated inward rectifier potassium channel 2 (A9 dopaminergic neuronal marker) were positive in the lesioned side of striatum in the human. brain-derived neural stem cell group. The use of early-stage human dental papilla-derived stem cells confirmed its tendency to form tumors. Human brain-derived neural stem cells could be partially differentiated into dopaminergic neurons, but they did not secrete dopamine.
Keywords
MULTIPLE SYSTEM ATROPHY; RAT MODEL; SUBTHALAMIC NUCLEUS; IN-VITRO; DIFFERENTIATION; MICE; 6-HYDROXYDOPAMINE; STIMULATION; DOPAMINE; LEVODOPA; neural regeneration; stem cells; cell transplantation; glucose metabolism; human brain-derived neural stem cells; human dental papilla-derived stem cells; Parkinson' s disease; positron emission tomography; grants-supported paper; neuroregeneration
ISSN
1673-5374
URI
https://pubs.kist.re.kr/handle/201004/128082
DOI
10.3969/j.issn.1673-5374.2013.13.004
Appears in Collections:
KIST Article > 2013
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE